A new study reveals intermittent fasting successfully reduces multiple sclerosis like symptoms. Mice who fasted every other day were less likely to develop motor problems associated with the disease.
A new study may pinpoint an alternative treatment for people with drug resistant multiple sclerosis.
Researchers have succeeded in regenerating myelin in mouse models of multiple sclerosis, protecting neurons from the disease and helping to restore function.
According to a new study, an experimental drug called laquinimod may help to prevent the development of and reduce the progression of multiple sclerosis.
Researchers identify a key protein which helps maintain the blood-brain barrier.
Researchers report the Del-1 protein reduces the severity of a disease equivalent to MS in mice.